Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Anemia, Sickle Cell D000755 34 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dermatomycoses D003881 17 associated lipids
Gonorrhea D006069 7 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Manzoni P et al. Prevention of nosocomial infections in neonatal intensive care units. 2013 Am J Perinatol pmid:23292914
Ouyang W et al. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells. 2013 Int. J. Oncol. pmid:23258590
Giuliano S et al. Candidemia in Neurosurgical Intensive Care Unit: preliminary analysis of the effect of topical Nystatin prophylaxis and adequate source control on patients with early tracheostomy intubation. 2013 Jan-Feb Ann Ig pmid:23435780
Sklenár Z et al. Compounded preparations with nystatin for oral and oromucosal administration. 2013 Jul-Aug Acta Pol Pharm pmid:23923400
Gøtzsche PC and Johansen HK Nystatin prophylaxis and treatment in severely immunodepressed patients. 2014 Cochrane Database Syst Rev pmid:25188770
Johansen HK and Gøtzsche PC Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. 2014 Cochrane Database Syst Rev pmid:25188769
Anil S et al. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals. 2014 Mycopathologia pmid:25142726
Chulkov EG et al. Direct visualization of solid ordered domains induced by polyene antibiotics in giant unilamellar vesicles. 2014 Chem. Phys. Lipids pmid:25068758
Lewis M The role of antifungal and antiviral agents in primary dental care. 2014 Prim Dent J pmid:25668378
Ellepola AN et al. The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates. 2014 Mycoses pmid:23773155
Li D et al. Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. 2014 Mycoses pmid:23952962
Kristanc L et al. The role of sterols in the lipid vesicle response induced by the pore-forming agent nystatin. 2014 Biochim. Biophys. Acta pmid:24863056
Serhan G et al. The polyene antifungals, amphotericin B and nystatin, cause cell death in Saccharomyces cerevisiae by a distinct mechanism to amphibian-derived antimicrobial peptides. 2014 Ann. Clin. Microbiol. Antimicrob. pmid:24884795
Mandigers PJ et al. The clinical significance of Cyniclomyces guttulatus in dogs with chronic diarrhoea, a survey and a prospective treatment study. 2014 Vet. Microbiol. pmid:24908274
Ruhil S et al. In vitro evaluation of combination of polyenes with EDTA against Aspergillus spp. by different methods (FICI and CI Model). 2014 J. Appl. Microbiol. pmid:24931000
Curvelo JA et al. Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? 2014 Arch. Oral Biol. pmid:24907522
Hussein-Al-Ali SH et al. Antimicrobial and controlled release studies of a novel nystatin conjugated iron oxide nanocomposite. 2014 Biomed Res Int pmid:24900976
Rivarola de Gutierrez E et al. Topical treatment of oral lichen planus with anthocyanins. 2014 Med Oral Patol Oral Cir Bucal pmid:24880442
Lollis TR and Bradshaw WT Fungal prophylaxis in neonates: a review article. 2014 Adv Neonatal Care pmid:24472884
Ellepola AN and Samaranayake LP Impact of brief and sequential exposure to nystatin on the germ tube formation and cell surface hydrophobicity of oral Candida albicans isolates from human immunodeficiency virus-infected patients. 2014 Med Princ Pract pmid:24801278
Valitova J et al. Sterol binding by methyl-β-cyclodextrin and nystatin--comparative analysis of biochemical and physiological consequences for plants. 2014 FEBS J. pmid:24612537
Popa I et al. Expression and subcellular localization of RAGE in melanoma cells. 2014 Biochem. Cell Biol. pmid:24697697
Gitrowski C et al. Uptake of different crystal structures of TiOâ‚‚ nanoparticles by Caco-2 intestinal cells. 2014 Toxicol. Lett. pmid:24576787
Mansourian A et al. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study. 2014 J Mycol Med pmid:25442923
Choukri F et al. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. 2014 J Mycol Med pmid:25442913
Piña-Vázquez C et al. Identification of phosphatidylcholine transfer protein-like in the parasite Entamoeba histolytica. 2014 Biochimie pmid:25223890
Boros-Majewska J et al. Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis. 2014 Med. Microbiol. Immunol. pmid:24924305
Katyukhin LN A method for evaluation of membrane permeability for water by the erythrocyte osmotic deformability profiles. 2014 Bull. Exp. Biol. Med. pmid:24915951
Gerstein AC et al. Loss-of-heterozygosity facilitates passage through Haldane's sieve for Saccharomyces cerevisiae undergoing adaptation. 2014 Nat Commun pmid:24804896
Sheikh S et al. Fluorescence imaging of human cells with a novel conjugate of the antifungal nystatin. 2014 Med Chem pmid:24725140
Chukwuneke F et al. Concurrent Presentation of Burning Mouth Syndrome and Globus Pharyngis in Enugu, Nigeria: A Ten-year Clinical Evaluation. 2014 Oral Health Prev Dent pmid:24624402
Hemmateenejad B et al. Photodegradation study of nystatin by UV-Vis spectrophotometry and chemometrics modeling. 2014 Jul-Aug J AOAC Int pmid:25145159
Ren J et al. Enhancement of nystatin production by redirecting precursor fluxes after disruption of the tetramycin gene from Streptomyces ahygroscopicus. 2014 Jul-Aug Microbiol. Res. pmid:24231162
Rizk NN et al. Use of topical lidocaine, diphenhydramine hydrochloride, nystatin, and gabapentin swish in treatment for post-radiation neuropathy and oral mucositis. 2014 May-Jun Pain Physician pmid:24850125
Jakab Á et al. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy. 2015 J. Basic Microbiol. pmid:25707543
Okechukwu DC et al. Evaluation of the anti-candidal activity of methanolic leaf extract of cleistopholis patens (fam. Annonaceae) on candida species isolated from stage II HIV patients. 2015 Afr Health Sci pmid:26957966
Chen Y et al. Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration. 2015 Int. J. Cancer pmid:24798787
Sasek V Consequences of Misnomer or Mistakes in Identification of Fungal Species. 2015 Int J Med Mushrooms pmid:26853957
Guerra CM et al. Duration of prophylaxis against fungal infection in kidney transplant recipients. 2015 Prog Transplant pmid:26645924
Austin N et al. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. 2015 Cochrane Database Syst Rev pmid:26497202
Farrag HA et al. Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis. 2015 Int. J. Radiat. Biol. pmid:25758055
Korany MA et al. Application of derivative spectrophotometry under orthogonal polynomial at unequal intervals: determination of metronidazole and nystatin in their pharmaceutical mixture. 2015 Spectrochim Acta A Mol Biomol Spectrosc pmid:25748283
Schulz JC et al. Unfolding and folding internal friction of β-hairpins is smaller than that of α-helices. 2015 J Phys Chem B pmid:25741584
Wang MM et al. Mutagenicity of ZnO nanoparticles in mammalian cells: Role of physicochemical transformations under the aging process. 2015 Nanotoxicology pmid:25676621
Yao JY et al. Evaluation of nystatin isolated from Streptomyces griseus SDX-4 against the ciliate, Ichthyophthirius multifiliis. 2015 Parasitol. Res. pmid:25645004
Moriyama T et al. Caveolae may enable albumin to enter human renal glomerular endothelial cells. 2015 J. Cell. Biochem. pmid:25640083
Semis R et al. Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods. 2015 J Mycol Med pmid:25639922
Martín MJ et al. Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery. 2015 Carbohydr Polym pmid:25498619
Fan S et al. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. 2015 Mycopathologia pmid:25416649
Bueno MG et al. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm. 2015 Oral Dis pmid:24219354